- Home
- CMND vs EDSA Comparison
CMND vs EDSA Comparison
Compare CMND & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- EDSA
- Stock Information
- Founded
- CMND 2017
- EDSA 2015
- Country
- CMND Canada
- EDSA Canada
- Employees
- CMND N/A
- EDSA N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- CMND Health Care
- EDSA Health Care
- Exchange
- CMND Nasdaq
- EDSA Nasdaq
- Market Cap
- CMND 6.0M
- EDSA 6.2M
- IPO Year
- CMND N/A
- EDSA N/A
- Fundamental
- Price
- CMND $1.13
- EDSA $2.38
- Analyst Decision
- CMND
- EDSA Strong Buy
- Analyst Count
- CMND 0
- EDSA 1
- Target Price
- CMND N/A
- EDSA $21.00
- AVG Volume (30 Days)
- CMND 56.1K
- EDSA 5.9M
- Earning Date
- CMND 04-15-2025
- EDSA 05-09-2025
- Dividend Yield
- CMND N/A
- EDSA N/A
- EPS Growth
- CMND N/A
- EDSA N/A
- EPS
- CMND N/A
- EDSA N/A
- Revenue
- CMND N/A
- EDSA N/A
- Revenue This Year
- CMND N/A
- EDSA N/A
- Revenue Next Year
- CMND N/A
- EDSA N/A
- P/E Ratio
- CMND N/A
- EDSA N/A
- Revenue Growth
- CMND N/A
- EDSA N/A
- 52 Week Low
- CMND $0.95
- EDSA $1.55
- 52 Week High
- CMND $2.30
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- CMND 39.96
- EDSA 55.16
- Support Level
- CMND $1.05
- EDSA $2.20
- Resistance Level
- CMND $1.16
- EDSA $2.55
- Average True Range (ATR)
- CMND 0.06
- EDSA 0.21
- MACD
- CMND -0.00
- EDSA 0.00
- Stochastic Oscillator
- CMND 27.30
- EDSA 69.09
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.